The Limb Salvage Center

Filter Your Results




A Different Approach

Robert M. Bersin, MD

September 2006—Employing a bidirectional technique for treating an iliac CTO.

SFA Revascularization Using the Viabahn Endoprosthesis

Richard D. Coats, MD; John G. Adams, Jr, MD; and Paul W. Humphrey, MD

September 2006—Technical considerations from a challenging case.

Improving Quality of Life

David E. Allie, MD; Chris J. Hebert, RT(R), R-CIS; Raghotham Patlola, MD; and Craig M. Walker, MD

September 2006—The legs, the heart, and sex: What is the connection? An iliac artery case report.

Treating Complex Femoropopliteal Lesions

Takao Ohki, MD, PhD

September 2006—A case presentation showing how modern endovascular tools can facilitate optimal treatment.

Laser Treatment

Robert Gallino, MD

September 2006—Using the Spectranetics Turbo catheter to treat a calcified lesion and a thrombotic occlusion in the SFA

Embolic Protection in Femoropopliteal Artery Intervention

Hank J. Freeman, MD, and John H. Rundback, MD

October 2006—What devices are available and when is it necessary?

The Final Rule

Roseanne R. Wholey

October 2006—The 2007 hospital in-patient prospective payment system final rule.

An Interview With David H. Deaton, MD

November 2006—A prominent vascular surgeon shares his experiences with AAA devices, the PAD Coalition, and how surgery is a family business.



US Device Guide

The Endovascular Today Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.